Loading clinical trials...
Loading clinical trials...
This is a prospective birth cohort study assessing the role of maternal and environmental factors on the development of allergic diseases in children. Pregnant mothers will be enrolled and we will examine her skin barrier with skin tape strips (STS) and transepidermal water loss (TEWL), along with blood work. We will then follow her offspring and perform similar testing, along with detailed questionnaires inquiring about exposures such as use of detergents and soaps, sunlight exposure, and pollution exposure. When the infant is around 12 months old, we will contact the family via telephone to see if the child developed any allergic conditions within their first year of life, such as eczema, food allergy, or wheezing. A final questionnaire will be performed.
Age
0 - 55 years
Sex
ALL
Healthy Volunteers
Yes
National Jewish Health
Denver, Colorado, United States
Start Date
August 3, 2020
Primary Completion Date
July 1, 2022
Completion Date
July 1, 2022
Last Updated
September 10, 2020
160
ESTIMATED participants
Transepidermal water loss
DIAGNOSTIC_TEST
Skin tape stripping
DIAGNOSTIC_TEST
Blood draw
DIAGNOSTIC_TEST
Bacterial PCR swab
DIAGNOSTIC_TEST
Lead Sponsor
National Jewish Health
NCT06406114
NCT06273683
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06258902